P.J. Schmidt Investment Management (PJS)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

P.J. Schmidt Investment Management (PJS)’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-6,895	Closed	-$356K	–	135
2016 Q1	$356K	Sell	6,895 -435	-6%	-$22.6K	0.14%	111
2015 Q4	$515K	Sell	7,330 -200	-3%	-$13.6K	0.21%	98
2015 Q3	$469K	Sell	7,530 -105	-1%	-$8.28K	0.2%	100
2015 Q2	$642K	Sell	7,635 -30	-0.4%	-$2.33K	0.25%	99
2015 Q1	$576K	Sell	7,665 -210	-3%	-$14.7K	0.23%	101
2014 Q4	$489K	Sell	7,875 -9,204	-54%	-$525K	0.19%	105
2014 Q3	$888K	Buy	17,079 +120	+0.7%	+$6.12K	0.36%	75
2014 Q2	$870K	Sell	16,959 -9	-0.1%	-$406	0.34%	75
2014 Q1	$806K	Buy	16,968 +4,758	+39%	+$244K	0.32%	82
2013 Q4	$530K	Buy	12,210 +255	+2%	+$10.6K	0.22%	96
2013 Q3	$515K	Buy	11,955 +555	+5%	+$22.5K	0.24%	87
2013 Q2	$396K	Buy	+11,400	New	+$401K	0.19%	87

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

P.J. Schmidt Investment Management (PJS)'s XBI Position: Q2 2016 in Review

P.J. Schmidt Investment Management (PJS) sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2016, closing a stake of 6,895 shares — an estimated $356K sold.

P.J. Schmidt Investment Management (PJS) first reported a position in XBI in Q2 2013 and held it in 12 quarters. The position peaked at $888K in Q3 2014. 201 funds tracked by Wall St. Rank hold XBI as of Q2 2016.

P.J. Schmidt Investment Management (PJS) reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2016 after selling out during the quarter.
P.J. Schmidt Investment Management (PJS) sold 6,895 State Street SPDR S&P Biotech ETF shares in Q2 2016, an estimated $356K.
P.J. Schmidt Investment Management (PJS) first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 12 quarters.
P.J. Schmidt Investment Management (PJS)'s State Street SPDR S&P Biotech ETF position peaked at $888K in Q3 2014.
201 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2016.

Based on P.J. Schmidt Investment Management (PJS)'s 13F filing for Q2 2016, filed 9 Aug 2016.